Table 2.
Mean FLIO Lifetimes in Healthy Subjects and AMD Patients
| Area of Interest |
Healthy (n
= 45) |
Neovascular AMD (n
= 29) |
Non-neovascular
AMD
(n
= 17) |
P
Value |
||
|
Healthy and Neovascular AMD |
Healthy and Nonneovascular AMD |
Neovascular and Nonneovascular AMD |
||||
| Central area (C) | ||||||
| SSC, ps | 223 ± 80 | 152 ± 63 | 190 ± 76 | <0.001 | 0.135 | 0.066 |
| LSC, ps | 309 ± 66 | 273 ± 79 | 296 ± 58 | 0.062 | 0.464 | 0.303 |
| Outer ring (OR) | ||||||
| SSC, ps | 327 ± 80 ps | 369 ± 62 | 388 ± 78 | <0.05 | <0.01 | 0.353 |
| LSC, ps | 361 ± 63 ps | 470 ± 36 | 438 ± 32 | <0.001 | <0.001 | <0.05 |
| Difference (OR minus C) | ||||||
| SSC, ps | 104 ± 26 | 217 ± 56 | 198 ± 40 | <0.001 | <0.001 | 0.219 |
| LSC, ps | 53 ± 26 | 196 ± 75 | 141 ± 57 | <0.001 | <0.001 | <0.05 |
| Area of PED | ||||||
| SSC, ps | NA | 302 ± 91 | 349 ± 59 | NA | NA | 0.058 |
| LSC, ps | NA | 409 ± 72 | 435 ± 102 | NA | NA | 0.682 |
Bolded P values indicate statistical significance.